课题基金 / 基金详情

A conditional mouse model of Alzheimer's disease

A conditional mouse model of Alzheimer's disease
阿尔茨海默病的条件小鼠模型
批准号:
6694189
负责人:
TERRENCE C TOWN
金额:
$3.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-15 至 2006-08-14

项目摘要

项目成果

TERRENCE C TOWN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): An understanding of Alzheimer's disease (AD) etiology and evaluation of potential therapeutic modalities is critically dependent upon animal models of the disease. The utility of current non-inducible animal models of AD is limited, due to 1) possible developmental effects of transgene overexpression from birth which could influence AD-like pathology, and 2) inability to turn transgene expression "off" in adult animals to determine the effect of transgene inactivation on AD-like pathology. The focus of this proposal is to address these issues by establishing a transgenic mouse model of AD that overexpresses mutant human amyloid precursor protein (mhAPP) under the tetracycline (tat) regulated system. In specific aim 1, a construct containing a tetO responsive promoter and a mutant human APP cDNA (tetO-mhAPP) will be generated and validated. In specific aim 2, mice (designated Tet/mhAPP) that conditionally express mhAPP in the forebrain under tat regulatory control will be generated. Specific aim 3 will investigate the kinetics of AD-like pathology in Tet/mhAPP mice in which transgene expression is induced postnatally. Finally, in specific aim 4, possible reversal of AD-like pathology will be examined by blocking mhAPP expression in aged mice with established AD-like pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rebalancing Innate Immunity in Alzheimer's disease by deleting IRAK-M
Rebalancing Innate Immunity in Alzheimer's disease by deleting IRAK-M
An iPS Disease-in-a-Dish Model of Familial Alzheimers
Peripheral TGF-beta Pathway Inhibitor Therapy in Alzheimer's Rats
海外基金